FDA warns telaprevir can cause fatal rash

Patients taking telaprevir for hepatitis C are at risk of developing a serious skin rash that could be fatal, the Food and Drug Administration has warned. » More

Share »

Sunscreen regulations take effect

The Food and Drug Administration's final rule for sunscreen labeling requirements went into effect Dec. 17, impacting manufacturers with annual product sales of more than $25,000.
» More

Share »

Can you afford to miss this meeting?

The Business of Medicine Summit (Philadelphia, Feb 23-24 2013) is a CME-CERTIFIED meeting focused on the practical aspects of running a successful practice. Presented by nationally-recognized experts, topics will include practice management, electronic health records, risk management, healthcare reform and health policy, reimbursement, corporate tax structure, and many other topics focused on supporting today's and tomorrow's physicians and medical practices.Visit:www.bizmedicine.org

fyi...

58%

Percentage of adults in the U.S. who practice sun-protective behaviors

Source: Centers for Disease Control and Prevention

Dermatology Times' Laser and Light 2012 special supplement is available!

Read about today's hottest laser and light technologies by visiting: dermatologytimes.com/laserandlight2012

Off-label marketing gets free speech protection

A recent court ruling allows pharmaceutical representatives to tell doctors about appropriate off-label uses of medications without risking a penalty from federal authorities. » More

Share »

Cosmetic camouflage provides emotional benefits

Patients who have visible facial skin conditions such as acne and vitiligo can derive emotional benefits from cosmetic camouflage therapy, results of a recent study indicate. » More

Share »